Citation Impact
Citing Papers
Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Eradication therapy for peptic ulcer disease in Helicobacter pylori -positive people
2016
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
B‐CELL LYMPHOMA OF MALT TYPE: A REVIEW WITH SPECIAL EMPHASIS ON DIAGNOSTIC AND MANAGEMENT PROBLEMS OF LOW‐GRADE GASTRIC TUMOURS
1998
“Rescue” regimens after Helicobacter pylori treatment failure
2008
Structures of MLSBK Antibiotics Bound to Mutated Large Ribosomal Subunits Provide a Structural Explanation for Resistance
2005 StandoutNobel
Acromegaly
2006 Standout
Systematic review and meta‐analysis: is 1‐week proton pump inhibitor‐based triple therapy sufficient to heal peptic ulcer?
2005
The analysis of onion and garlic
2006 Standout
13C-urea breath test in the management of Helicobacter pylori infection
2005
Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north-east of Spain
2005
Gastric Stromal Sarcoma, Pulmonary Chondroma, and Extra-adrenal Paraganglioma (Carney Triad): Natural History, Adrenocortical Component, and Possible Familial Occurrence
1999
Cancers Associated with Acromegaly
2006
Functional Gastroduodenal Disorders
2006 Standout
Fungal Urosepsis After Ureteroscopy in Cirrhotic Patients: A Word of Caution
2008
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Allicin disrupts the cell's electrochemical potential and induces apoptosis in yeast
2010
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying
1998
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
2002 StandoutNobel
Percutaneous Drainage Compared with Surgery for Hepatic Hydatid Cysts
1997
Effect of Helicobacter pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura-A Randomized Controlled Trial
2005
Diabetes and cardiovascular disease
2000
Echinococcosis
2003 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type
2009
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
2008
Acromegaly, growth hormone and cancer risk
2008
Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer
2004
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Efecto de la actuación farmacéutica en la adherencia del tratamiento farmacológico de pacientes ambulatorios con riesgo cardiovascular (Estudio EMDADER-CV-INCUMPLIMIENTO)
2011
The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine
2011
Correlation of serology with morphological changes in gastric biopsy in Helicobacter pylori infection and evaluation of immunohistochemistry for H. pylori identification
2012
Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori
2007
Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
2013
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series: Figure 1
2007
Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review
2013
Stewart's quantitative acid-base chemistry: Applications in biology and medicine
1993
Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-Regression
2011
Secondary Aeromonas peritonitis is associated with polymicrobial ascites culture and absence of liver cirrhosis compared to primary Aeromonas peritonitis
2006
Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail
2002
Helicobacter pylori Recurrence in Developed and Developing Countries: Meta‐Analysis of 13C‐Urea Breath Test Follow‐Up after Eradication
2008
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue
2005
Epidemiology of Acromegaly
1999
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori
2010
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Helicobacter pylori infection and gastric lymphoma
1998
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts
2003
Resistencia de Helicobacter pylori al metronidazol y a la claritromicina en España. Una revisión sistemática
2001
Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors
2002
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels
2009
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2003
Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
1998 Standout
Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding
2004
Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy
2000
Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis
2004
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines
2010
Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure
2005
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradication
2005
Pulmonary–Hepatic vascular Disorders (PHD)
2004
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial
2002
Using serum pepsinogens wisely in a clinical practice
2007
Long-Term Results of Anti– Helicobacter pylori Therapy in Early-Stage Gastric High-Grade Transformed MALT Lymphoma
2005
Helicobacter pyloriInfection
2002 Standout
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis
2001
Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer
2005
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
Treatment of Helicobacter pylori Infection: A Review of the World Literature
1996
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Pooled Analysis on the Efficacy of the Second-line Treatment Regimens for Helicobacter pylori Infection
2001
Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity
2006
Comparison of three different second‐line quadruple therapies including bismuth subcitrate in Turkish patients with non‐ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14‐day standard first‐line therapy
2007
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Systematic review: Heliocobacter pylori infection and impaired drug absorption
2008
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylorieradication
2000
Risk factors for coronary heart disease and infection with Helicobacter pylori : meta-analysis of 18 studies
1998
Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan
2011
Non–Gastrointestinal Tract Associations of Helicobacter pylori Infection
1999
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Association of Helicobacter Pylori Infection With Gastric Carcinoma: A Meta-Analysis
1999
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria
2001 StandoutNatureNobel
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis
2006
Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy
2005
Pulmonary Arterial Hypertension in France
2006 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Gut Microbiota in Health and Disease
2010 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
23S rRNA 2058A→G Alteration Mediates Ketolide Resistance in Combination with Deletion in L22
2006 StandoutNobel
The gastric marginal zone B-cell lymphoma of MALT type
2000
Parasiticidal Effect of Chemotherapy in Alveolar Hydatid Disease: Review of Experience with Mebendazole and Albendazole in Alaskan Eskimos
1992
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
A review of human carcinogens—Part B: biological agents
2009 Standout
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2004
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Allicin: Chemistry and Biological Properties
2014 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacy
2000
Use of a Substrate/Alliinase Combination To Generate Antifungal Activity in Situ
2005
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Allicin and related compounds: Biosynthesis, synthesis and pharmacological activity
2011
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma
2001
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Interventions for enhancing medication adherence
2014 Standout
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
2001
Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre
2013
The GenusAeromonas: Taxonomy, Pathogenicity, and Infection
2010 Standout
Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24‐h pH monitoring
1999
Control of plant diseases by natural products: Allicin from garlic as a case study
2008
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
2012
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Concordance ofHelicobacter pyloriStrains within Families
2003
The gastric marginal zone B-cell lymphoma of MALT type
2000
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
The impact of Helicobacter pylori eradication on peptic ulcer healing
1998
Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura
2001
Food Processing and the Mediterranean Diet
2015
Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocolitica
2011
Ribosomal Crystallography: Initiation, Peptide Bond Formation, and Amino Acid Polymerization are Hampered by Antibiotics
2004 StandoutNobel
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
2005
Works of D Boixeda being referenced
Basal and Stimulated Gastrin Levels and Gastric Acid Output Five Months After Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients
1996
Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori
1999
Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis
1993
Role of partner's infection in reinfection after Helicobacter pylori eradication
2002
Helicobacter pylori Infection Is Markedly Increased in Patients With Autoimmune Atrophic Thyroiditis
1998
Relation between Histologic Subtypes and Location of Gastric Cancer andHelicobacter pylori
1997
Adherence to treatment in inflammatory bowel disease
2005
Thermal Degradation of Allicin in Garlic Extracts and Its Implication on the Inhibition of the in-Vitro Growth of Helicobacter pylori
2004
Re-treatment after Helicobacter pylon eradication failure
1999
Neoplastic Colonic Polyps in Acromegaly
1994
Verification of Decreased Basal and Stimulated Serum Pepsinogen-I Levels Is a Useful Non-Invasive Method for Determining the Success of Eradication Therapy forHelicobacter pylori
1996
Allyl-thiosulfinates, the Bacteriostatic Compounds of Garlic against Helicobacter pylori
2004
Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study
2005
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection
2002
Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy
2001
Helicobacter pylori infection in a healthy population in Spain
1996
Etiology and frequency of gas exchange abnormalities in cirrhosis.
1999
[Helicobacter pylori and duodenal ulcer: a causal relation or mere association?].
1997
Yersinia enterocolitica Septicemia
1980
Helicobacter pylori eradication versus one-year maintenance therapy: effect on relapse and gastritis outcome.
2001
[Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
1999
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
1996
Hyperventilation with hypoproteinemia.
1988
[Is gastric cancer an infectious disease?].
1996
[Why, when and how to treat Helicobacter pylori infection in gastroduodenal ulcer disease?].
1996
Treatment of liver hydatid disease with mebendazole: a prospective study of thirteen cases.
1983
[The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
1995
[Is there a relationship between digestive symptoms and H. pylori infection?].
1995
Mutations in 23S rRNA in Helicobacter pylori Conferring Resistance to Erythromycin Do Not Always Confer Resistance to Clarithromycin
1999
Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
2001
Galenical formulations of amoxicillin/clavulanate and eradication of Helicobacter pylori in peptic ulcer patients
1993
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
1996
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
1995
[Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
1995
The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: Parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement
2001
[Carney's triad: a short review apropos a case].
1992
Spontaneous peritonitis due to Klebsiella oxytoca in a patient with cardiac ascites.
1988
Healing of Helicobacter pylori gastric ulcers: only eradication matters.
2003
Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: Follow-up together with sequential molecular studies
1997
Helicobacter pylori infection, serum triglyceride and serum cholesterol levels: A step atherosclerosis?
1998
Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies.
1997
Helicobacter pylori infection and diabetes mellitus
1998
Association of Helicobacter pylori Infection With Cardiovascular and Cerebrovascular Disease in Diabetic Patients
1998
Usefulness of the combined IgG and IgA antibody determinations for serodiagnosis of Helicobacter pylori infection.
1997
Consideraciones prácticas para el diagnóstico de la infección por Helicobacter pylori
2001
Leukocyte diferential count and Helicobacter pylori infection
1998
[Helicobacter pylori and non-ulcer dyspepsia: a pending matter].
1998